Cory Kasimov
Stock Analyst at Evercore ISI
(4.92)
# 215
Out of 4,974 analysts
1015
Total ratings
61.4%
Success rate
20%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTC Benitec Biopharma | Maintained: Buy | $25 | $12.08 | +106.95% | 2 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $65 → $72 | $51.85 | +38.86% | 3 | Sep 15, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $130 | $72.38 | +79.61% | 20 | Sep 14, 2026 | |
| MRNA Moderna | Reiterated: Hold | $50 → $80 | $146.69 | -45.46% | 49 | Sep 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $325 | $249.99 | +30.09% | 8 | Aug 31, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $100 | $72.45 | +38.03% | 12 | Aug 31, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $230 → $320 | $205.11 | +56.01% | 7 | Aug 27, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $210 → $215 | $157.22 | +36.75% | 17 | Aug 17, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $24.55 | +62.93% | 8 | Aug 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $120 | $66.41 | +80.70% | 84 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $44.62 | +23.26% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $58.19 | +37.48% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $22 | $10.77 | +104.37% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $24.12 | +86.57% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $98.86 | +31.50% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $12.65 | +97.63% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $535 | $519.51 | +2.98% | 61 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $40.47 | +23.55% | 1 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 → $825 | $793.74 | +3.94% | 77 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $18.42 | +84.58% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $5.81 | +158.18% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $31.91 | +72.36% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 → $128 | $13.61 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $84 | $16.22 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $45.83 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $219 → $221 | $217.36 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $27.52 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $3.20 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $1.78 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 → $16 | $2.74 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 → $227 | $381.50 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $98 → $86 | $122.19 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $18.53 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $18.55 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $74 | $146.41 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $9.14 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $88.71 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.38 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.3886 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.75 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $100 | $1,138.28 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $276.72 | $8.25 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.1475 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.49 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.60 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $9.59 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $68 | $51.44 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $350.13 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $8.23 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.000001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.35 | n/a | 1 | Jun 4, 2013 |
Benitec Biopharma
Sep 15, 2026
Maintained: Buy
Price Target: $25
Current: $12.08
Upside: +106.95%
Scholar Rock Holding
Sep 15, 2026
Maintained: Buy
Price Target: $65 → $72
Current: $51.85
Upside: +38.86%
BridgeBio Pharma
Sep 14, 2026
Reiterated: Buy
Price Target: $130
Current: $72.38
Upside: +79.61%
Moderna
Sep 11, 2026
Reiterated: Hold
Price Target: $50 → $80
Current: $146.69
Upside: -45.46%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $325
Current: $249.99
Upside: +30.09%
Cytokinetics
Aug 31, 2026
Reiterated: Buy
Price Target: $100
Current: $72.45
Upside: +38.03%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $230 → $320
Current: $205.11
Upside: +56.01%
Neurocrine Biosciences
Aug 17, 2026
Reiterated: Buy
Price Target: $210 → $215
Current: $157.22
Upside: +36.75%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $24.55
Upside: +62.93%
BioMarin Pharmaceutical
Aug 7, 2026
Reiterated: Buy
Price Target: $120
Current: $66.41
Upside: +80.70%
Aug 7, 2026
Reiterated: Buy
Price Target: $55
Current: $44.62
Upside: +23.26%
Aug 7, 2026
Reiterated: Buy
Price Target: $80
Current: $58.19
Upside: +37.48%
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $22
Current: $10.77
Upside: +104.37%
Aug 5, 2026
Reiterated: Buy
Price Target: $45
Current: $24.12
Upside: +86.57%
Aug 5, 2026
Reiterated: Buy
Price Target: $130
Current: $98.86
Upside: +31.50%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $12.65
Upside: +97.63%
Aug 4, 2026
Reiterated: Buy
Price Target: $535
Current: $519.51
Upside: +2.98%
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $40.47
Upside: +23.55%
May 18, 2026
Reiterated: Buy
Price Target: $875 → $825
Current: $793.74
Upside: +3.94%
May 1, 2026
Reiterated: Buy
Price Target: $34
Current: $18.42
Upside: +84.58%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $5.81
Upside: +158.18%
Mar 17, 2026
Reiterated: Buy
Price Target: $55
Current: $31.91
Upside: +72.36%
Jul 29, 2022
Reiterated: Buy
Price Target: $126 → $128
Current: $13.61
Upside: n/a
Jul 28, 2022
Reiterated: Hold
Price Target: $91 → $84
Current: $16.22
Upside: n/a
Jul 27, 2022
Reiterated: Hold
Price Target: $30 → $33
Current: $45.83
Upside: n/a
Jul 20, 2022
Reiterated: Hold
Price Target: $219 → $221
Current: $217.36
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $27.52
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $14 → $11
Current: $3.20
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $24 → $20
Current: $1.78
Upside: n/a
May 4, 2022
Reiterated: Sell
Price Target: $19 → $16
Current: $2.74
Upside: n/a
Apr 28, 2022
Reiterated: Hold
Price Target: $235 → $227
Current: $381.50
Upside: n/a
Feb 9, 2022
Reiterated: Hold
Price Target: $98 → $86
Current: $122.19
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: $61
Current: $18.53
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $18.55
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $74
Current: $146.41
Upside: n/a
Feb 25, 2021
Reiterated: Sell
Price Target: n/a
Current: $9.14
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $88.71
Upside: n/a
Nov 13, 2019
Reiterated: Buy
Price Target: n/a
Current: $41.38
Upside: n/a
Jun 26, 2018
Reiterated: Sell
Price Target: n/a
Current: $0.3886
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $3.75
Upside: n/a
Apr 11, 2017
Reiterated: Buy
Price Target: $384 → $100
Current: $1,138.28
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $276.72
Current: $8.25
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.1475
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $1.49
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $1.60
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $9.59
Upside: n/a
Jun 8, 2015
Reiterated: Hold
Price Target: $65 → $68
Current: $51.44
Upside: n/a
Jan 13, 2015
Reiterated: Hold
Price Target: n/a
Current: $350.13
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $8.23
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.000001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $45.35
Upside: n/a